1 / 34

Ethics and Reprogenetic Technologies GBI International Bioethics Summer School 2019

This overview of reprogenetic technologies explores the use of assisted reproductive technologies, genetic technologies, and specific ethical issues. It discusses arguments for and against reprogenetics and highlights the complexities involved.

amildred
Télécharger la présentation

Ethics and Reprogenetic Technologies GBI International Bioethics Summer School 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ethics and Reprogenetic TechnologiesGBI International Bioethics Summer School 2019 Inmaculada de Melo-Martin, PhD Professor of Medical Ethics in Medicine Professor of Medical Ethics in Reproductive Medicine Professor of Healthcare Policy and Research

  2. Overview • Reprogenetic Technologies • Assisted Reproductive Technologies (ARTs) • Genetic Technologies • Arguments for and against the use of Reprogenetics • Specific Ethical Issues

  3. Reprogenetic Technologies

  4. Reprogenetic Technologies

  5. Reprogenetic Technologies About 7 million babies have been born worldwide Around 1.5 million ART cycles are performed each year worldwide, with an estimated 350,000 babies born. Currently, in several European countries including Belgium, Denmark, and Norway, more than 4.0% of all babies are born through IVF. In the United States, approximately 1.5% of all infants born now are conceived with the help of these technologies. European Society of Human Reproduction and Embryology 2013-2015 CDC, Assisted Reproductive Technology National Summary Report. 2014

  6. Reprogenetic Technologies • Europe leads the world in ART, initiating approximately 55% of all reported ART cycles.  • France, Germany, Italy, Russia, Spain, and the UK are Europe's most active countries. • The most active countries in the world are Japan and the USA. European Society of Human Reproduction and Embryology 2013-2015 CDC, Assisted Reproductive Technology National Summary Report. 2014

  7. Reprogenetic Technologies IVF Cryopreservation of sperm, oocytes, and embryos PGD Virtual Babies Somatic and Germline Modifications

  8. IVF & ET • A process by which an oocyte is fertilized by prepared sperm outside the body –in vitro • The process involves:

  9. ICSI

  10. Risks To Women Risks related to hormones Ovarian hyperstimulation syndrome Multiple births Women’s status

  11. PGD

  12. PGD Comprehensive genetic testing techniques such as microarrays and whole genome sequencing, which can screen many chromosomes or genes simultaneously, are currently being evaluated for introduction in the clinic. Such techniques can provide information on hundreds of mutations and variants related not only to disease risks but also to some non–health-related traits (Kumar et al. 2015).

  13. PGD Use of PGD for social sex selection is increasing

  14. Risks Risks of misdiagnosis Damage to the biopsied embryos, which can result in developmental lag and increased rates of embryonic death before uterine implantation Initial evidence regarding children’s health indicates that babies born after PGD show normal neurodevelopment, comparable to that of naturally conceived children (Liebaerset al. 2010). Nonetheless, data concerning long-term health outcomes is nonexistent because PGD is a relatively new technology.

  15. Virtual Babies

  16. Genetic Engineering Technologies

  17. Genetic Engineering Technologies Somatic modifications Germline modifications

  18. Germline Modifications • Mitochondrial Transfer Technologies • Only a handful of children born through their application • Clinical trials currently under way in some countries such as the UK • CRISP-Cas 9 • Twin baby girls reportedly born in China

  19. Ethical Issues

  20. Ethical Issues • Ethical concerns about the use of reprogenetic technologies are very complex because they involve: • An activity that is essential to human and societal wellbeing • The use of powerful technologies • The practice of medicine • A variety of stakeholders with sometimes conflicting interests: • Prospective Parents • Sperm and Egg donors • Clinicians • Societies

  21. Arguments for Reprogenetics • Reproductive Freedom • Right Not to Procreate: • Contraception • Abortion • Right to Procreate: • Force sterilization bans • Access to reprogenetics

  22. Arguments for Reprogenetics • Parental Autonomy • Choices that influence a child’s initial endowment • Partner characteristics • Choices that influence a child’s social starting point in life. • When to reproduce • Choices about how to raise one’s child

  23. Arguments for Reprogenetics To the extent that reproductive liberty and parental autonomy are thought to be basic rights, interference with reproductive decisions is seen as morally and legally legitimate onlywhen such decisions clearly and seriously harm others

  24. Some Problems • Reproductive freedom: what does it entail? • Reproductive freedom does not entail a right to have a particular kind of child • Parental autonomy: what does it entail? • Parental autonomy needs to be evaluated within a sophisticated conception of autonomy that involves normative notions of parenthood • What constitutes harm? Who is an appropriate subject of harm? How to balance harm considerations?

  25. Arguments Against Reprogenetics • Deontological arguments • Commodification objections • Treating children merely as means to their parents’ ends • Threats to our self-understanding

  26. Some Problems • Plurality of conceptions of the good • Children need to be treated merely as means • Non-identity problem

  27. Arguments Against Reprogenetics • Consequentialists arguments • Safety: of women, of children • Physical • Psychological • Risks to society • Devaluing of women, of children • Increased inequality • Conceptions of parenthood • Slippery slope

  28. Some Problems • Autonomy of women • Non-identity problem • Solutions through regulations

  29. SpesicicIssues

  30. Specific Issues • How much power should prospective parents have? • Are prospective parents morally required to use reprogenetic technologies? • For selection purposes? • For enhancement purposes? • What moral obligations do clinicians have?

  31. Specific Issues • How much power should prospective parents have? • Selecting against disability? • Why? • What disabilities? • Causing disable children to exist? • Why not? • What disabilities? • Selecting for/against non-disease traits? • Why not? • What traits?

  32. References Brock, D. W. (1995) The Nonidentity Problem and Genetic Harms - The Case of Wrongful Handicaps, Bioethics, 9(3-4), 269-275. de Melo-Martin, I. 2017. Rethinking Reprogenetics. New York: Oxford University Press. Green, R. 2007. Babies by Design. New Haven: Yale University Press. Habermas, J. (2003) The future of human nature, Cambridge, UK: Polity. Harman, E. (2004) Can we harm and benefit in creating?, Philosophical Perspectives, 18(1), 89-113. Harris, J. 2007. Enhancing Evolution. Princeton: Princeton University Press. Parfit, D. (1984) Reasons and persons, Oxford: Clarendon Press. Savulescu, J. 2005. New breeds of humans: The moral obligation to enhance. Reprod Biomed Online10:36-39. Robertson, J. A. (1994) Children of choice: freedom and the new reproductive technologies, Princeton: Princeton University Press.

  33. QUESTIONS? Thank You!

More Related